lobbying_activities: 825640
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 825640 | 1c1aaac1-75d9-4984-bcfd-e1c219dfcdbb | Q3 | POLICY DIRECTIONS INC. | 31747 | QRXPHARMA LIMITED | 2009 | third_quarter | MED | Collaboration in licensing of PTSD/acute depression use of scopolamine; NIH/Office of Technology Transfer | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) | 10000 | 0 | 0 | 2009-10-13T11:44:55-04:00 |